Literature DB >> 24595942

The effect of garlic powder on human urinary cytokine excretion.

Ergun Alma1, Alper Eken2, Hakan Ercil3, Kazim Yelsel4, Nebile Daglioglu5.   

Abstract

PURPOSE: To evaluate the effects of orally administered dehydrated garlic powder on cytokine excretion in the urinary tract.
MATERIALS AND METHODS: A total of 60 healthy volunteers, randomized into 3 groups, were given a single oral dose of 1 g or 3 g of dehydrated garlic powder or placebo. Urine samples were obtained 6.0 and 24.0 h after garlic intake and assayed for interleukin-8 (IL-8), interleukin- 12 (IL-12), tumor necrosis factor-alpha (TNF-α), diallyl disulfide (DADS) and diallyl sulfide (DAS).
RESULTS: Significant increases in IL-12 levels over baseline were noted in urine samples obtained after oral intake of 1 g and 3 g of garlic powder (P < .001). In the 1 g and 3 g garlic powder treatment groups, time-dependent variations in IL-12 levels over the study period were significantly different from the placebo group (P < .001). In both garlic treatment groups, urinary levels of IL-8 and TNF-α were not significantly different from baseline and placebo levels (P > .017). DADS and DAS were not detected in the urine samples at any time after garlic powder intake.
CONCLUSION: Oral intake of doses of garlic traditionally used for daily supplementation increases urinary levels of IL-12, which is a potent stimulator of T helper cell 1 (Th-1) immune responses. This observation encourages further studies investigating the immunostimulatory role of garlic in the urinary tract.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24595942

Source DB:  PubMed          Journal:  Urol J        ISSN: 1735-1308            Impact factor:   1.510


  1 in total

Review 1.  Diallyl Disulfide: A Bioactive Garlic Compound with Anticancer Potential.

Authors:  Saikat Mitra; Rajib Das; Talha Bin Emran; Rafiuddin Khan Labib; Fahadul Islam; Rohit Sharma; Islamudin Ahmad; Firzan Nainu; Kumarappan Chidambaram; Fahad A Alhumaydhi; Deepak Chandran; Raffaele Capasso; Polrat Wilairatana
Journal:  Front Pharmacol       Date:  2022-08-22       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.